Early Insights from Commercialization of Gene Therapies in Europe

by Nicolas Touchot, Mathias Flume
Published 2017-02-01

Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries

by Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Lars-Ake Levin, Maarten J. Postma, Nicolas Touchot
Published 2018-01-01